Search results
Results From The WOW.Com Content Network
With the exception of active duty service members (who are assigned to the Tricare Prime option and pay no out-of-pocket costs for Tricare coverage), Military Health System beneficiaries may have a choice of Tricare plan options depending upon their status (e.g., active duty family member, retiree, reservist, child under age 26 ineligible for ...
The program was originally authorized in Section 701(g) of the National Defense Authorization Act for Fiscal Year 2002 (Public Law 107-107) and is codified in law in 10 USC 1079 (d) through (g). Department of Defense regulations for the ECHO program are found at 32 CFR 199.5 after being published in the August 20, 2004 Federal Register (69 FR ...
One month after passage, the administration estimated that the net cost of the program over the period between 2006 (the first year the program started paying benefits) and 2015 would be $534 billion. [19] As of February 2009, the projected net cost of the program over the 2006 to 2015 period was $549.2 billion. [20]
The Defense Health Agency (DHA) is a joint, integrated combat support agency that enables the U.S. Army, U.S. Navy, and U.S. Air Force medical services to provide a medically ready force and ready medical force to Combatant Commands in both peacetime and wartime.
In late 1993, driven by requirements in the DoD Appropriation Act for Fiscal Year 1994, DoD announced plans to implement by May 1997 a nationwide managed care program for the MHS. Under this program, known as TRICARE, the United States would be divided into 12 health care regions. An administrative organization, the lead agent, was designated ...
The Assistant Secretary of Defense for Health Affairs (ASD(HA)) is chartered under United States Department of Defense Directive (DoDD) 5136.1 [1] in 1994. This DoDD states that the ASD(HA) is the principal advisor to the U.S. Secretary of Defense on all "DoD health policies, programs and activities."
The Prescription Drug User Fee Act (PDUFA) was a law passed by the United States Congress in 1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process.
Help; Learn to edit; Community portal; Recent changes; Upload file; Special pages